MedTech Strategist’s Post

For Parkinson’s disease, deep brain stimulation (DBS) is far more effective and safer than drugs for managing the condition’s motor symptoms. DBS, like any therapy addressing a particular biological target, is most effective and tolerable when it hits the mark. To address the movement disorders that affect patients with Parkinson’s disease (PD) and essential tremor, DBS needs to stop the problematic signals coming from the ventral intermediate nucleus (VIM) in the subthalamus region of the brain, which requires placing stimulation leads with an accuracy of one millimeter or less from the target. With the help of artificial intelligence, RebrAIn (Pessac, France and Newark, DE) has developed a service that provides neurosurgeons with the information they need for accurate lead placement imminently before the surgery. The start-up’s software as a service model suits the demands of the busy operating suite, “which doesn’t need another computer or box,” notes David Caumarti, the company’s CEO. RebrAIn is providing an AI-enabled service that helps neurosurgeons more precisely localize the target of therapy in the individual’s brain to guide more accurate intervention for Parkinson’s disease, essential tremor, and other neurodegenerative disorders: https://bit.ly/3VVeO6F #medicaldevices #medtech #Parkinsons #deepbrainstimulation #artificialintelligence

  • For Parkinson’s disease, deep brain stimulation (DBS) is far more effective and safer than drugs for managing the condition’s motor symptoms. DBS, like any therapy addressing a particular biological target, is most effective and tolerable when it hits the mark. To address the movement disorders that affect patients with Parkinson’s disease (PD) and essential tremor, DBS needs to stop the problematic signals coming from the ventral intermediate nucleus (VIM) in the subthalamus region of the brain, which requires placing stimulation leads with an accuracy of one millimeter or less from the target.



With the help of artificial intelligence, RebrAIn (Pessac, France and Newark, DE) has developed a service that provides neurosurgeons with the information they need for accurate lead placement imminently before the surgery. The start-up’s software as a service model suits the demands of the busy operating suite, “which doesn’t need another computer or box,” notes David Caumarti, the company’

To view or add a comment, sign in

Explore topics